{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:35:49Z","timestamp":1774125349136,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1016\/s0091-6749(99)70467-7","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T07:48:22Z","timestamp":1131004102000},"page":"427-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity"],"prefix":"10.1016","volume":"103","author":[{"given":"J.Mark","family":"FitzGerald","sequence":"first","affiliation":[]},{"given":"Kenneth R.","family":"Chapman","sequence":"additional","affiliation":[]},{"given":"Giovanni Della","family":"Cioppa","sequence":"additional","affiliation":[]},{"given":"David","family":"Stubbing","sequence":"additional","affiliation":[]},{"given":"Mary Sue","family":"Fairbarn","sequence":"additional","affiliation":[]},{"given":"M.Denise","family":"Till","sequence":"additional","affiliation":[]},{"given":"Reto","family":"Brambilla","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0091-6749(99)70467-7_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1183\/09031936.93.05070896","article-title":"Regular \u03b2-agonist therapy\u2014the quality of evidence","volume":"5","author":"Sears","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/S0091-6749(99)70467-7_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0954-6111(96)80005-9","article-title":"Controversies in respiratory medicine: regular inhaled \u03b2-agonists\u2014Clear clinical benefit or hazard to health? (2) Why \u03b2-agonists should not be used regularly","volume":"86","author":"Page","year":"1992","journal-title":"Respir Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.309.6957.794","article-title":"Use of \u03b22 -agonists in asthma: Much ado about nothing? Still cause for concern","volume":"109","author":"Tattersfield","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/S0091-6749(99)70467-7_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1378\/chest.106.2.552","article-title":"Regular \u03b2-adrenergic agonists: evidence, not reassurance, is what is needed","volume":"106","author":"Taylor","year":"1994","journal-title":"Chest"},{"key":"10.1016\/S0091-6749(99)70467-7_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm\/151.3_Pt_1.600","article-title":"Is the routine use of inhaled \u03b2-adrenergic agonists appropriate in asthma treatment? No","volume":"151","author":"Sears","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(89)92505-1","article-title":"Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study","volume":"1","author":"Crane","year":"1989","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/S0091-6749(99)70467-7_bib7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1136\/thx.50.Suppl_1.S5","article-title":"Asthma and the \u03b2-agonist debate","volume":"50","author":"Crane","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/S0091-6749(99)70467-7_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM199202203260801","article-title":"The use of \u03b2-agonists and the risk of death and near death from asthma","volume":"326","author":"Spitzer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib9","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0140-6736(90)93098-A","article-title":"Regular inhaled \u03b2-agonist treatment in bronchial asthma","volume":"336","author":"Sears","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S0091-6749(99)70467-7_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/thx.48.2.134","article-title":"Regular inhaled \u03b2-agonists in asthma: effects on exacerbations and lung function","volume":"48","author":"Taylor","year":"1993","journal-title":"Thorax"},{"key":"10.1016\/S0091-6749(99)70467-7_bib11","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/bmj.303.6815.1426","article-title":"Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on-demand? A randomized controlled study","volume":"303","author":"van Schayck","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/S0091-6749(99)70467-7_bib12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJM199210223271704","article-title":"Tolerance to nonbronchodilator effects of inhaled\u03b22 -agonists in asthma","volume":"327","author":"O\u2019Connor","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0140-6736(93)92695-P","article-title":"Regular inhaled salbutamol and airway responsiveness to allergen","volume":"342","author":"Cockcroft","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0091-6749(99)70467-7_bib14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(94)92520-8","article-title":"Regular vs as-needed inhaled salbutamol in asthma control","volume":"343","author":"Chapman","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0091-6749(99)70467-7_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199508243330807","article-title":"\u03b2-Adrenergic bronchodilators","volume":"333","author":"Nelson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199609193351202","article-title":"Comparison of regularly scheduled with as-needed use of albuterol in mild asthma","volume":"335","author":"Drazen","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM199202203260809","article-title":"The \u03b2-agonist dilemma","volume":"326","author":"Burrows","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199210223271703","article-title":"Long-term effects of a\u03b22 -adrenoceptor long-acting agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma","volume":"327","author":"Cheung","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib19","first-page":"363","article-title":"Reduced protection against exercise-induced bronchoconstriction after chronic dosing with salmeterol","volume":"88","author":"Ramage","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1378\/chest.108.5.1235","article-title":"Rapid onset of tolerance to the bronchoprotective effect of salmeterol","volume":"108","author":"Bhagat","year":"1995","journal-title":"Chest"},{"key":"10.1016\/S0091-6749(99)70467-7_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1164\/ajrccm.152.4.7551366","article-title":"Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment","volume":"152","author":"Yates","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/thx.50.5.497","article-title":"Subsensitivity of bronchodilator and systemic\u03b22 -adrenoceptor responses after twice daily treatment with formoterol dry powder in asthmatic patients","volume":"50","author":"Newnham","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/S0091-6749(99)70467-7_bib23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0091-6749(96)80068-6","article-title":"Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma","volume":"97","author":"Verbene","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0091-6749(99)70467-7_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/pulp.1993.1020","article-title":"Effect on airway responsiveness of six weeks treatment with salmeterol","volume":"6","author":"Beach","year":"1993","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/S0091-6749(99)70467-7_bib25","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1056\/NEJM199211123272004","article-title":"A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma","volume":"327","author":"Pearlman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jama.1994.03510420044032","article-title":"Salmeterolxinafoate as maintenance therapy compared with albuterol in patients with asthma","volume":"271","author":"D\u2019Alonzo","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/S0091-6749(99)70467-7_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.306.6880.776","article-title":"Guidelines for the management of asthma: a summary","volume":"306","author":"British Thoracic Society and others","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/S0091-6749(99)70467-7_bib28","series-title":"Expert panel report 2 for the diagnosis and management of asthma","author":"National Asthma Education Program","year":"1997"},{"key":"10.1016\/S0091-6749(99)70467-7_bib29","first-page":"89","article-title":"Canadian asthma consensus conference summary of recommendations","volume":"3","author":"Ernst","year":"1996","journal-title":"Can Respir J"},{"key":"10.1016\/S0091-6749(99)70467-7_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","article-title":"American Thoracic Society standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma","volume":"136","author":"American Thoracic Society","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/S0091-6749(99)70467-7_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2222.1977.tb01448.x","article-title":"Bronchial reactivity to inhaled histamine: a method and clinical survey","volume":"7","author":"Cockcroft","year":"1977","journal-title":"Clin Allergy"},{"key":"10.1016\/S0091-6749(99)70467-7_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/thx.33.6.705","article-title":"Reproducibility and comparison of response to inhaled histamine and methacholine","volume":"33","author":"Juniper","year":"1978","journal-title":"Thorax"},{"key":"10.1016\/S0091-6749(99)70467-7_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.84.4.505","article-title":"Determination of histamine PC20. Comparison of linear and logarithmic interpolation","volume":"84","author":"Cockcroft","year":"1983","journal-title":"Chest"},{"key":"10.1016\/S0091-6749(99)70467-7_bib34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0954-6111(96)80004-7","article-title":"Controversies in respiratory medicine: regular inhaled \u03b2-agonists\u2014Clear clinical benefit or a hazard to health? 1. \u03b2-Agonists can be used safely and beneficially in asthma","volume":"86","author":"Twentyman","year":"1992","journal-title":"Respir Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib35","first-page":"898","article-title":"\u03b2-Agonists\u2014still more friends than foes","volume":"5","author":"L\u00f6fdahl","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/S0091-6749(99)70467-7_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1164\/ajrccm\/151.3_Pt_1.597","article-title":"Is the routine use of inhaled \u03b2-adrenergic agonists appropriate in asthma treatment? Yes","volume":"151","author":"Wanner","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1183\/09031936.95.08050673","article-title":"Present state of the controversy about regular inhaled \u03b2-agonists in asthma","volume":"8","author":"Giuntini","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/S0091-6749(99)70467-7_bib38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJM199609193351211","article-title":"Inhaled \u03b22 -agonists in the treatment of asthma","volume":"335","author":"O\u2019Byrne","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0091-6749(99)70467-7_bib39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/thx.51.11.1100","article-title":"Salmeterol tachyphylaxis in steroid treated subjects","volume":"51","author":"Booth","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/S0091-6749(99)70467-7_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/clpt.1982.204","article-title":"Reversal of human lymphocyte \u03b2-adrenoreceptor desensitization by glucocorticoids","volume":"32","author":"Hui","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0091-6749(99)70467-7_bib41","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI112063","article-title":"Terbutaline-induced desensitization of human lymphocyte \u03b22 -adrenoreceptors: accelerated restoration of \u03b2-adrenoreceptor responsiveness by prednisolone and ketotifen","volume":"76","author":"Brodde","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/S0091-6749(99)70467-7_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1378\/chest.109.4.953","article-title":"Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol","volume":"109","author":"Kalra","year":"1996","journal-title":"Chest"},{"key":"10.1016\/S0091-6749(99)70467-7_bib43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(88)91352-9","article-title":"Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline","volume":"1","author":"Vathenen","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/S0091-6749(99)70467-7_bib44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0091-6749(85)90786-9","article-title":"Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline","volume":"76","author":"Kraan","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0091-6749(99)70467-7_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0091-6749(87)80163-X","article-title":"Effect of long-term treatment with inhaled corticosteroids and \u03b2-agonists on the bronchial responsiveness in children with asthma","volume":"79","author":"Kerrebijin","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0091-6749(99)70467-7_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/ajrccm\/148.3.707","article-title":"Asthma control during and after cessation of regular \u03b22-agonist treatment","volume":"148","author":"Wahedna","year":"1993","journal-title":"Am Rev Respir Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674999704677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674999704677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:05:39Z","timestamp":1758787539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674999704677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S0091674999704677"],"URL":"https:\/\/doi.org\/10.1016\/s0091-6749(99)70467-7","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0091-6749(99)70467-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}